A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

VX-264OngoingActive not recruitingPhase 1Open NCT05791201 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT05791201 · Trial Tracker · ComplyRx